Author:
Tolvanen Liisa,Ghilotti Francesca,Adami Hans-Olov,Ye Weimin,Bonn Stephanie E.,Bellocco Rino,Lagerros Ylva Trolle
Abstract
AbstractEffects of repeated weight changes on mortality are not well established. In this prospective cohort study, we followed 34,346 individuals from 1997 to 2018 for all-cause mortality, and 2016 for cause-specific mortality. At baseline, participants self-reported amount and frequency of prior weight loss. During 20.6 (median) years of follow-up, we identified 5627 deaths; 1783 due to cancer and 1596 due to cardiovascular disease (CVD). We used Cox Proportional Hazards models to estimate multivariable‐adjusted Hazard Ratios (HRs) and 95% confidence intervals (CI). Participants with a weight loss > 10 kg had higher rates of all-cause (HR 1.22; 95%CI 1.09–1.36) and CVD mortality (HR 1.27; 95%CI 1.01–1.59) compared to individuals with no weight loss. Men who had lost > 10 kg had higher all-cause (HR 1.55; 95%CI 1.31–1.84) and CVD mortality (HR 1.55; 95%CI 1.11–2.15) compared to men with no weight loss. Participants who had lost ≥ 5 kg three times or more prior to baseline had increased rates of all-cause (HR 1.16; 95%CI 1.03–1.30) and CVD mortality (HR 1.49; 95%CI 1.20–1.85) compared to participants with no weight loss. We found no association between weight loss and cancer mortality. We conclude that previous and repeated weight loss may increase all-cause and CVD mortality, especially in men.
Funder
Region Stockholm, Sweden
Karolinska Institutet, Sweden
Karolinska Institute
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. World Health Organization. Overweight and Obesity: World Health Organization https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Updated 9 July 2021. Accessed 11 Mar 2022 (2021).
2. Rueda-Clausen, C. F., Ogunleye, A. A. & Sharma, A. M. Health benefits of long-term weight-loss maintenance. Annu. Rev. Nutr. 35, 475–516 (2015).
3. Ryan, D. H. & Yockey, S. R. Weight loss and improvement in comorbidity: Differences at 5%, 10%, 15%, and over. Curr. Obes. Rep. 6(2), 187–194 (2017).
4. Look Ahead Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring) 22(1), 5–13 (2014).
5. Wilding, J. P. H. et al. Once-weekly semaglutide in adults with overweight or obesity. N. Engl. J. Med. 384(11), 989 (2021).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献